P2.02. Neoadjuvant Immunotherapy Related Pneumonitis in Non-Small Cell Lung Cancer Patients: Incidence, Risk Factors, and Management - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Long Jiang
Meta Tag
Speaker Long Jiang
Topic Local-Regional NSCLC: Toxicities of Multimodality Therapy
checkpoint inhibitor pneumonitis
non-small cell lung cancer
neoadjuvant immunotherapy
clinical characteristics
medical records
C-reactive protein level
systemic corticosteroid therapy
respiratory failure
Powered By